Ameritas Advisory Services LLC Buys Shares of 4,113 Encompass Health Co. (NYSE:EHC)

Ameritas Advisory Services LLC bought a new stake in shares of Encompass Health Co. (NYSE:EHCFree Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 4,113 shares of the company’s stock, valued at approximately $380,000.

Other institutional investors have also modified their holdings of the company. State Street Corp boosted its stake in Encompass Health by 0.7% during the third quarter. State Street Corp now owns 3,025,769 shares of the company’s stock valued at $292,410,000 after buying an additional 21,329 shares in the last quarter. Geode Capital Management LLC boosted its position in Encompass Health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock worth $161,781,000 after acquiring an additional 20,547 shares during the period. Copeland Capital Management LLC lifted its position in Encompass Health by 1.0% in the 3rd quarter. Copeland Capital Management LLC now owns 1,284,550 shares of the company’s stock worth $124,139,000 after buying an additional 12,433 shares in the last quarter. Point72 Asset Management L.P. boosted its stake in shares of Encompass Health by 2,458.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock valued at $83,990,000 after buying an additional 835,135 shares during the period. Finally, Thrivent Financial for Lutherans raised its stake in shares of Encompass Health by 26.0% during the 3rd quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company’s stock worth $73,494,000 after purchasing an additional 156,938 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Encompass Health Price Performance

Shares of NYSE EHC opened at $95.28 on Friday. The firm has a market capitalization of $9.60 billion, a P/E ratio of 23.02, a P/E/G ratio of 1.14 and a beta of 0.89. The firm’s 50-day moving average price is $96.80 and its 200-day moving average price is $94.20. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health Co. has a 1-year low of $69.95 and a 1-year high of $104.55.

Encompass Health (NYSE:EHCGet Free Report) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.94 by $0.09. The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company’s revenue for the quarter was up 11.9% on a year-over-year basis. During the same quarter last year, the business posted $0.86 EPS. Equities research analysts anticipate that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Royal Bank of Canada increased their target price on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Barclays boosted their price objective on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Truist Financial reaffirmed a “buy” rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Finally, KeyCorp boosted their target price on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Nine analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, Encompass Health presently has an average rating of “Buy” and a consensus target price of $107.11.

Check Out Our Latest Stock Report on EHC

About Encompass Health

(Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Further Reading

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHCFree Report).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.